On scaffolds and hopping in medicinal chemistry

被引:117
作者
Brown, Nathan [1 ]
Jacoby, Edgar [1 ]
机构
[1] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland
关键词
scaffold; scaffold hopping; markush; isofunctional; lead hopping; chemoinformatics;
D O I
10.2174/138955706778742768
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The molecular scaffold is an oft-cited concept in medicinal chemistry suggesting that the definition of what makes a scaffold is rigorous and objective. However, this is far from the case with the definition of a scaffold being highly dependent on the particular viewpoint of a given scientist. It follows, therefore, that the definition of scaffold hopping and, more importantly, the detection of what constitutes a scaffold hop, is also ill-defined and highly subjective. Essentially, it is agreed that scaffolds. should be substantially different from each other, although significantly similar to each other, to constitute a hop. In the latter, the scaffolds must permit a similar geometric arrangement of functional groups to permit the mode of action, However, this leaves the paradox of how to describe both scaffold similarity and dissimilarity simultaneously. In this paper, the current statuses of scaffolds and scaffold hopping are reviewed based on published examples of scaffold hopping from the literature. An investigation of the degree to which it is possible to formulate a more rigorous definition of scaffolds and hopping in the context of molecular topologies is considered. These techniques are adapted from chemoinformatics to be applied in the design of new medicinal compounds.
引用
收藏
页码:1217 / 1229
页数:13
相关论文
共 64 条
[31]   New methods for ligand-based virtual screening: Use of data fusion and machine learning to enhance the effectiveness of similarity searching [J].
Hert, J ;
Willett, P ;
Wilton, DJ ;
Acklin, P ;
Azzaoui, K ;
Jacoby, E ;
Schuffenhauer, A .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2006, 46 (02) :462-470
[32]   Use of the R-group descriptor for alignment-free QSAR [J].
Hirons, L ;
Holliday, JD ;
Jelfs, SP ;
Willett, P ;
Gedeck, P .
QSAR & COMBINATORIAL SCIENCE, 2005, 24 (05) :611-619
[33]   A 3D similarity method for scaffold hopping from the known drugs or natural ligands to new chemotypes [J].
Jenkins, JL ;
Glick, M ;
Davies, JW .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) :6144-6159
[34]   Non-peptide cholecystokinin-B/gastrin receptor antagonists based on bicyclic, heteroaromatic skeletons [J].
Kalindjian, SB ;
Buck, IM ;
Davies, JMR ;
Dunstone, DJ ;
Hudson, ML ;
Low, CMR ;
McDonald, IM ;
Pether, MJ ;
Steel, KIM ;
Tozer, MJ ;
Vinter, JG .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (09) :1806-1815
[35]   Chemical similarity using physiochemical property descriptors [J].
Kearsley, SK ;
Sallamack, S ;
Fluder, EM ;
Andose, JD ;
Mosley, RT ;
Sheridan, RP .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1996, 36 (01) :118-127
[36]   Charting biologically relevant chemical space: A structural classification of natural products (SCONP) [J].
Koch, MA ;
Schuffenhauer, A ;
Scheck, M ;
Wetzel, S ;
Casaulta, M ;
Odermatt, A ;
Ertl, P ;
Waldmann, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (48) :17272-17277
[37]   Novel technologies for virtual screening [J].
Lengauer, T ;
Lemmen, C ;
Rarey, M ;
Zimmermann, M .
DRUG DISCOVERY TODAY, 2004, 9 (01) :27-34
[38]   Scaffold hopping in de novo design. Ligand generation in the absence of receptor information [J].
Lloyd, DG ;
Buenemann, CL ;
Todorov, NP ;
Manallack, DT ;
Dean, PM .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (03) :493-496
[39]   Scaffold hopping with molecular field points: Identification of a cholecystokinin-2 (CCK2) receptor pharmacophore and its use in the design of a prototypical series of pyrrole- and imidazole-based CCK2 antagonists [J].
Low, CMR ;
Buck, IM ;
Cooke, T ;
Cushnir, JR ;
Kalindjian, SB ;
Kotecha, A ;
Pether, MJ ;
Shankley, NP ;
Vinter, JG ;
Wright, L .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (22) :6790-6802
[40]  
Markush E.A., 1924, Pyrazolone dye and process of making the same, Pharma Chemical Corp, Patent Number: 1506316, United States, Patent No. [1,506,316, 1506316]